We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
CNCR

Price
9.02
Stock movement up
+- (%)
Company name
Loncar Cancer Immunotherapy ETF
Exchange
(NASDAQ
,
Currency
USD
)
Market cap
-
Ent value
-
Price/Sales
-
Price/Book
-
Div yield
20.55%
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-38.11%
3 year return
-13.81%
5 year return
-19.18%
10 year return
-
Last updated: 2025-09-02

DIVIDENDS

CNCR does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales-
Price to Book-
EV to Sales-

FINANCIALS

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open9.02
Daily high9.02
Daily low9.02
Daily Volume0K
All-time high35.70
1y analyst estimate-
Beta0.96
EPS (TTM)-
Dividend per share1.85
Ex-div date29 Dec 2021
Next earnings date-

Downside potential

Loading...
Downside potential data
CNCRS&P500
Current price drop from All-time high-74.73%-2.75%
Highest price drop-77.56%-19.00%
Date of highest drop8 Apr 20258 Apr 2025
Avg drop from high-36.25%-2.76%
Avg time to new high127 days5 days
Max time to new high1084 days89 days
COMPANY DETAILS
CNCR (Loncar Cancer Immunotherapy ETF) company logo
Marketcap
-
Marketcap category
Mid-cap
Description
The index was established in 2023 by Range Fund Holdings and tracks the performance of a portfolio of U.S. exchange-listed pharmaceutical or biotechnology stocks or American Depositary Receipts ("ADRs") with a market capitalization of more than $250 million. The advisor attempts to invest all, or substantially all, of its assets in the component securities that make up the index. Under normal circumstances, at least 80% of the fund"s total assets will be invested in the component securities of the index.
Employees
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
Annual
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner